Carregant...
Tipus de document
ArticleVersió
Versió acceptadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/147238
Budd-Chiari syndrome with short-length stenosis: still room for the angioplasty and wait-and-see strategy
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
We read with interest the study in The Lancet Gastroenterology & Hepatology by Qiuhe Wang and colleagues. 1 This randomised controlled trial aimed to elucidate whether routine stenting plus angioplasty was superior to angioplasty alone for preventing restenosis in patients with Budd-Chiari syndrome with short-length stenosis. The authors found that patients treated with angioplasty plus routine stenting had a lower incidence of restenosis than did patients treated with angioplasty alone, with no differences in survival. Based on these findings, the authors suggested that stenting combined with angioplasty should be used as a first-line invasive treatment in patients with Budd-Chiari syndrome with short-length stenosis.
Matèries
Matèries (anglès)
Citació
Citació
FERRUSQUÍA ACOSTA, José, HERNÁNDEZ GEA, Virginia, TURON, Fanny, GARCÍA PAGÁN, Juan carlos. Budd-Chiari syndrome with short-length stenosis: still room for the angioplasty and wait-and-see strategy. _The Lancet Gastroenterology & Hepatology_. 2019. Vol. 4, núm. 11, pàgs. 823. [consulta: 12 de febrer de 2026]. [Disponible a: https://hdl.handle.net/2445/147238]